Consumer Health

Inflation is a key factor influencing the consumer health market in Greece, with price hikes being seen across most categories. Even though increases in prices vary by brand, most products have been subject to hikes. This has not had the same effect…

Consumer health is witnessing another strong performance in 2023 as the category continues to recover from the COVID-19 pandemic following the removal of all pandemic-related restrictions. As Irish people shift back to normal living habits without…

Consumer health is set to record moderate single-digit growth in current value terms in 2023. With the pandemic officially over, according to the World Health Organisation (WHO), Italians are keen to get back to their pre-COVID-19 lifestyles and this…

2023 saw a repeat of the moderate, sustainable growth that was registered in most categories of consumer health during 2022, with the prevailing background trends characterised by a return to some semblance of pre-pandemic normality in the daily…

The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Cough remedies and decongestants, which had seen strong growth during the pandemic period, saw more moderate growth in 2022 and 2023 as the contagion receded and public concern waned. Current value sales growth partly reflects inflationary pressures,…

Within OTC consumer health in France, value sales of cough, cold and allergy (hay fever) remedies are continuing to record the fastest growth in 2023, following a dynamic performance the previous year. Within the category, demand for various formats…

In May 2022, Greece lifted all COVID-19 related regulations. This included the compulsory use of face masks and social distancing rules, and although use of face masks remains fairly high in Greece compared to other European countries, it appears…

Cough, cold and allergy (hay fever) remedies are enjoying strong growth in 2023 as the category continues to recover from the sharp declines seen during the COVID-19 pandemic. Flu, common coughs and colds and seasonal allergies in the Irish…

Cough/cold remedies are set to see high single-digit growth in current value terms in 2023, with sales likely to benefit from a high number of cases of cold and flu in the 2023/2024 season. Furthermore, value sales will likely also be boosted by unit…

Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…

Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…

Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…

Dermatologicals is expected to register an increase in current value sales in 2023, partly as a result of the energy crisis stemming from the war in Ukraine, which is pushing up retail prices.

Value growth for dermatologicals continues to slow in 2023 as local consumers prioritise the treatment of other health concerns. According to a study led by the French Society of Dermatology (SFD), one in three French citizen suffers from a skin…

Dermatologicals has seen demand weaken in the post-pandemic period. While certain COVID-19 related habits, such as the use of hand sanitisers, remain relevant and people in Greece continue to use them much more than they did in the past, this is a…

Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…

Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…